
PubMed:22173873
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-11 | 3640 | denotes | Doxycycline |
T1 | 0-11 | CHEBI:60648 | denotes | Doxycycline |
T2 | 0-11 | D004318 | denotes | Doxycycline |
T3 | 0-11 | CHEBI:50845 | denotes | Doxycycline |
T5 | 0-11 | D004318 | denotes | Doxycycline |
T6 | 53-70 | D002545 | denotes | cerebral ischemia |
T7 | 53-70 | D002545 | denotes | cerebral ischemia |
T10 | 62-89 | D015427 | denotes | ischemia-reperfusion injury |
T11 | 62-89 | D015427 | denotes | ischemia-reperfusion injury |
T14 | 136-139 | P34722 | denotes | PKC |
T15 | 136-139 | P13678 | denotes | PKC |
T16 | 136-139 | P05130 | denotes | PKC |
T18 | 136-139 | PR:000045382 | denotes | PKC |
T17 | 136-139 | GO:0004697 | denotes | PKC |
T19 | 136-139 | C537180 | denotes | PKC |
T20 | 141-150 | GO:0023052 | denotes | signaling |
T21 | 154-158 | 10118 | denotes | rats |
T22 | 154-158 | 10116 | denotes | rats |
T23 | 154-158 | D051381 | denotes | rats |
T24 | 215-237 | CHEBI:63726 | denotes | neuroprotective agents |
T25 | 215-237 | D018696 | denotes | neuroprotective agents |
T26 | 215-237 | D018696 | denotes | neuroprotective agents |
T27 | 268-285 | D002545 | denotes | cerebral ischemia |
T28 | 268-285 | D002545 | denotes | cerebral ischemia |
T31 | 277-304 | D015427 | denotes | ischemia-reperfusion injury |
T32 | 277-304 | D015427 | denotes | ischemia-reperfusion injury |
T38 | 370-381 | 3640 | denotes | doxycycline |
T35 | 370-381 | CHEBI:60648 | denotes | doxycycline |
T36 | 370-381 | D004318 | denotes | doxycycline |
T37 | 370-381 | CHEBI:50845 | denotes | doxycycline |
T39 | 370-381 | D004318 | denotes | doxycycline |
T40 | 383-397 | CHEBI:144644 | denotes | a tetracycline |
T43 | 385-397 | 10395 | denotes | tetracycline |
T46 | 398-408 | D000900 | denotes | antibiotic |
T47 | 398-408 | D000900 | denotes | antibiotic |
T48 | 398-408 | CHEBI:33281 | denotes | antibiotic |
T49 | 463-472 | MOP:0000569 | denotes | reduction |
T52 | 489-518 | D015427 | denotes | ischemia-reperfusion injuries |
T53 | 489-518 | D015427 | denotes | ischemia-reperfusion injuries |
T56 | 539-544 | UBERON:6110636 | denotes | brain |
T57 | 539-544 | UBERON:0000955 | denotes | brain |
T59 | 565-568 | PR:P63003-1 | denotes | rat |
T60 | 565-568 | PR:Q2G0B1 | denotes | rat |
T61 | 565-568 | PR:Q8VHJ4 | denotes | rat |
T58 | 565-568 | 10116 | denotes | rat |
T62 | 565-568 | D051381 | denotes | rat |
T63 | 579-601 | UBERON:0001627 | denotes | middle cerebral artery |
T64 | 579-611 | D020244 | denotes | middle cerebral artery occlusion |
T65 | 579-611 | D020244 | denotes | middle cerebral artery occlusion |
T73 | 681-692 | 3640 | denotes | doxycycline |
T70 | 681-692 | CHEBI:60648 | denotes | doxycycline |
T71 | 681-692 | D004318 | denotes | doxycycline |
T72 | 681-692 | CHEBI:50845 | denotes | doxycycline |
T74 | 681-692 | D004318 | denotes | doxycycline |
T75 | 705-724 | UBERON:0000120 | denotes | blood-brain barrier |
T78 | 726-729 | UBERON:0000120 | denotes | BBB |
T92 | 784-803 | D017207 | denotes | Sprague-Dawley rats |
T102 | 904-915 | 3640 | denotes | doxycycline |
T99 | 904-915 | CHEBI:60648 | denotes | doxycycline |
T100 | 904-915 | D004318 | denotes | doxycycline |
T101 | 904-915 | CHEBI:50845 | denotes | doxycycline |
T103 | 904-915 | D004318 | denotes | doxycycline |
T107 | 979-990 | 3640 | denotes | doxycycline |
T104 | 979-990 | CHEBI:60648 | denotes | doxycycline |
T105 | 979-990 | D004318 | denotes | doxycycline |
T106 | 979-990 | CHEBI:50845 | denotes | doxycycline |
T108 | 979-990 | D004318 | denotes | doxycycline |
T109 | 1017-1020 | UBERON:0000120 | denotes | BBB |
T110 | 1033-1049 | D002544 | denotes | cerebral infarct |
T111 | 1033-1049 | D002544 | denotes | cerebral infarct |
T114 | 1079-1089 | D005070 | denotes | Evans blue |
T115 | 1079-1089 | D005070 | denotes | Evans blue |
T116 | 1079-1089 | CHEBI:82467 | denotes | Evans blue |
T117 | 1124-1127 | Q41249 | denotes | PCR |
T118 | 1124-1127 | O66148 | denotes | PCR |
T119 | 1124-1127 | Q59987 | denotes | PCR |
T120 | 1124-1127 | Q01289 | denotes | PCR |
T121 | 1124-1127 | O80333 | denotes | PCR |
T122 | 1124-1127 | P15904 | denotes | PCR |
T123 | 1124-1127 | Q9SDT1 | denotes | PCR |
T124 | 1124-1127 | Q39617 | denotes | PCR |
T128 | 1210-1221 | 3640 | denotes | doxycycline |
T125 | 1210-1221 | CHEBI:60648 | denotes | doxycycline |
T126 | 1210-1221 | D004318 | denotes | doxycycline |
T127 | 1210-1221 | CHEBI:50845 | denotes | doxycycline |
T129 | 1210-1221 | D004318 | denotes | doxycycline |
T130 | 1239-1248 | SO:0000119 | denotes | regulated |
T131 | 1267-1281 | GO:0070160 | denotes | tight junction |
T133 | 1273-1281 | SO:0000699 | denotes | junction |
T132 | 1273-1281 | UBERON:0007651 | denotes | junction |
T134 | 1282-1291 | Q9JKD6 | denotes | claudin-5 |
T135 | 1282-1291 | O00501 | denotes | claudin-5 |
T136 | 1282-1291 | PR:000005553 | denotes | claudin-5 |
T137 | 1282-1291 | Q2HJ22 | denotes | claudin-5 |
T139 | 1282-1291 | O54942 | denotes | claudin-5 |
T138 | 1282-1291 | D062507 | denotes | claudin-5 |
T141 | 1293-1301 | Q91049 | denotes | occludin |
T142 | 1293-1301 | Q6P6T5 | denotes | occludin |
T143 | 1293-1301 | Q9PUN1 | denotes | occludin |
T144 | 1293-1301 | Q16625 | denotes | occludin |
T145 | 1293-1301 | PR:000002207 | denotes | occludin |
T146 | 1293-1301 | Q61146 | denotes | occludin |
T147 | 1293-1301 | Q28269 | denotes | occludin |
T148 | 1293-1301 | Q28793 | denotes | occludin |
T149 | 1293-1301 | Q5RFS5 | denotes | occludin |
T140 | 1293-1301 | D062793 | denotes | occludin |
T150 | 1307-1311 | PR:P39447 | denotes | ZO-1 |
T151 | 1307-1311 | PR:Q07157 | denotes | ZO-1 |
T152 | 1307-1311 | PR:000016364 | denotes | ZO-1 |
T153 | 1372-1375 | Q41249 | denotes | PCR |
T154 | 1372-1375 | O66148 | denotes | PCR |
T155 | 1372-1375 | Q59987 | denotes | PCR |
T156 | 1372-1375 | Q01289 | denotes | PCR |
T157 | 1372-1375 | O80333 | denotes | PCR |
T158 | 1372-1375 | P15904 | denotes | PCR |
T159 | 1372-1375 | Q9SDT1 | denotes | PCR |
T160 | 1372-1375 | Q39617 | denotes | PCR |
T161 | 1395-1402 | 4716 | denotes | gelatin |
T162 | 1395-1402 | D005780 | denotes | gelatin |
T163 | 1395-1402 | CHEBI:5291 | denotes | gelatin |
T164 | 1441-1445 | SO:0000704 | denotes | gene |
T169 | 1450-1457 | SO:0000104 | denotes | protein |
T168 | 1450-1457 | PR:000000001 | denotes | protein |
T166 | 1450-1457 | CHEBI:36080 | denotes | protein |
T167 | 1450-1457 | CHEBI:11122 | denotes | protein |
T165 | 1450-1457 | GO:0003675 | denotes | protein |
T170 | 1487-1493 | UBERON:0027368 | denotes | matrix |
T171 | 1487-1512 | D020782 | denotes | matrix metalloproteinases |
T173 | 1514-1518 | D020782 | denotes | MMPs |
T174 | 1520-1523 | CHEBI:340824 | denotes | MMP |
T177 | 1520-1523 | CHEBI:59761 | denotes | MMP |
T178 | 1520-1525 | PR:P08253 | denotes | MMP-2 |
T179 | 1520-1525 | Q9GLE5 | denotes | MMP-2 |
T180 | 1520-1525 | P08253 | denotes | MMP-2 |
T181 | 1520-1525 | Q90611 | denotes | MMP-2 |
T183 | 1520-1525 | PR:Q8MPP3 | denotes | MMP-2 |
T184 | 1520-1525 | P33436 | denotes | MMP-2 |
T185 | 1520-1525 | PR:Q90611 | denotes | MMP-2 |
T186 | 1520-1525 | PR:P33436 | denotes | MMP-2 |
T187 | 1520-1525 | PR:000010479 | denotes | MMP-2 |
T188 | 1520-1525 | PR:P33434 | denotes | MMP-2 |
T189 | 1520-1525 | P33434 | denotes | MMP-2 |
T190 | 1520-1525 | P50757 | denotes | MMP-2 |
T182 | 1520-1525 | GO:0004228 | denotes | MMP-2 |
T191 | 1530-1533 | CHEBI:340824 | denotes | MMP |
T194 | 1530-1533 | CHEBI:59761 | denotes | MMP |
T195 | 1530-1535 | PR:P50282 | denotes | MMP-9 |
T196 | 1530-1535 | PR:P14780 | denotes | MMP-9 |
T197 | 1530-1535 | P14780 | denotes | MMP-9 |
T198 | 1530-1535 | PR:P41245 | denotes | MMP-9 |
T199 | 1530-1535 | P41246 | denotes | MMP-9 |
T200 | 1530-1535 | P41245 | denotes | MMP-9 |
T201 | 1530-1535 | PR:P52176 | denotes | MMP-9 |
T202 | 1530-1535 | P50282 | denotes | MMP-9 |
T204 | 1530-1535 | PR:000010491 | denotes | MMP-9 |
T205 | 1530-1535 | P52176 | denotes | MMP-9 |
T206 | 1530-1535 | O18733 | denotes | MMP-9 |
T203 | 1530-1535 | GO:0004229 | denotes | MMP-9 |
T207 | 1607-1615 | D007511 | denotes | ischemia |
T208 | 1607-1615 | D007511 | denotes | ischemia |
T212 | 1659-1670 | 3640 | denotes | doxycycline |
T209 | 1659-1670 | CHEBI:60648 | denotes | doxycycline |
T210 | 1659-1670 | D004318 | denotes | doxycycline |
T211 | 1659-1670 | CHEBI:50845 | denotes | doxycycline |
T213 | 1659-1670 | D004318 | denotes | doxycycline |
T217 | 1692-1703 | 3640 | denotes | doxycycline |
T214 | 1692-1703 | CHEBI:60648 | denotes | doxycycline |
T215 | 1692-1703 | D004318 | denotes | doxycycline |
T216 | 1692-1703 | CHEBI:50845 | denotes | doxycycline |
T218 | 1692-1703 | D004318 | denotes | doxycycline |
T219 | 1761-1764 | P34722 | denotes | PKC |
T220 | 1761-1764 | P13678 | denotes | PKC |
T221 | 1761-1764 | P05130 | denotes | PKC |
T223 | 1761-1764 | PR:000045382 | denotes | PKC |
T222 | 1761-1764 | GO:0004697 | denotes | PKC |
T224 | 1761-1764 | C537180 | denotes | PKC |
T227 | 1766-1770 | SO:0000234 | denotes | mRNA |
T225 | 1766-1770 | D012333 | denotes | mRNA |
T226 | 1766-1770 | CHEBI:33699 | denotes | mRNA |
T232 | 1775-1782 | SO:0000104 | denotes | protein |
T231 | 1775-1782 | PR:000000001 | denotes | protein |
T228 | 1775-1782 | GO:0003675 | denotes | protein |
T229 | 1775-1782 | CHEBI:36080 | denotes | protein |
T230 | 1775-1782 | CHEBI:11122 | denotes | protein |
T233 | 1789-1797 | D007511 | denotes | ischemia |
T234 | 1789-1797 | D007511 | denotes | ischemia |
T238 | 1866-1877 | 3640 | denotes | doxycycline |
T235 | 1866-1877 | CHEBI:60648 | denotes | doxycycline |
T236 | 1866-1877 | D004318 | denotes | doxycycline |
T237 | 1866-1877 | CHEBI:50845 | denotes | doxycycline |
T239 | 1866-1877 | D004318 | denotes | doxycycline |
T240 | 1886-1889 | UBERON:0000120 | denotes | BBB |
T241 | 1947-1957 | GO:0065007 | denotes | regulation |
T242 | 1961-1975 | GO:0070160 | denotes | tight junction |
T243 | 1961-1984 | D062725 | denotes | tight junction proteins |
T245 | 1967-1975 | SO:0000699 | denotes | junction |
T244 | 1967-1975 | UBERON:0007651 | denotes | junction |
T247 | 2003-2006 | CHEBI:340824 | denotes | MMP |
T250 | 2003-2006 | CHEBI:59761 | denotes | MMP |
T251 | 2003-2008 | PR:P08253 | denotes | MMP-2 |
T252 | 2003-2008 | Q9GLE5 | denotes | MMP-2 |
T253 | 2003-2008 | P08253 | denotes | MMP-2 |
T254 | 2003-2008 | Q90611 | denotes | MMP-2 |
T256 | 2003-2008 | PR:Q8MPP3 | denotes | MMP-2 |
T257 | 2003-2008 | P33436 | denotes | MMP-2 |
T258 | 2003-2008 | PR:Q90611 | denotes | MMP-2 |
T259 | 2003-2008 | PR:P33436 | denotes | MMP-2 |
T260 | 2003-2008 | PR:000010479 | denotes | MMP-2 |
T261 | 2003-2008 | PR:P33434 | denotes | MMP-2 |
T262 | 2003-2008 | P33434 | denotes | MMP-2 |
T263 | 2003-2008 | P50757 | denotes | MMP-2 |
T255 | 2003-2008 | GO:0004228 | denotes | MMP-2 |
T264 | 2007-2013 | PR:O04529 | denotes | 2, MMP |
T265 | 2010-2013 | CHEBI:340824 | denotes | MMP |
T268 | 2010-2013 | CHEBI:59761 | denotes | MMP |
T269 | 2010-2015 | PR:P50282 | denotes | MMP-9 |
T270 | 2010-2015 | PR:P14780 | denotes | MMP-9 |
T271 | 2010-2015 | P14780 | denotes | MMP-9 |
T272 | 2010-2015 | PR:P41245 | denotes | MMP-9 |
T273 | 2010-2015 | P41246 | denotes | MMP-9 |
T274 | 2010-2015 | P41245 | denotes | MMP-9 |
T275 | 2010-2015 | PR:P52176 | denotes | MMP-9 |
T276 | 2010-2015 | P50282 | denotes | MMP-9 |
T278 | 2010-2015 | PR:000010491 | denotes | MMP-9 |
T279 | 2010-2015 | P52176 | denotes | MMP-9 |
T280 | 2010-2015 | O18733 | denotes | MMP-9 |
T277 | 2010-2015 | GO:0004229 | denotes | MMP-9 |
T281 | 2021-2024 | P34722 | denotes | PKC |
T282 | 2021-2024 | P13678 | denotes | PKC |
T283 | 2021-2024 | P05130 | denotes | PKC |
T285 | 2021-2024 | PR:000045382 | denotes | PKC |
T284 | 2021-2024 | GO:0004697 | denotes | PKC |
T286 | 2021-2024 | C537180 | denotes | PKC |
PubMed_ArguminSci
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 160-359 | DRI_Challenge | denotes | The strategy for the development of effective and safe neuroprotective agents has great potential to reduce cerebral ischemia-reperfusion injury and improve the functional outcome in stroke patients. |
T2 | 360-552 | DRI_Challenge | denotes | Recently, doxycycline, a tetracycline antibiotic, has been shown to have neuroprotective efficiency in reduction of a variety of ischemia-reperfusion injuries as well as ischemic brain damage. |
T3 | 553-778 | DRI_Approach | denotes | We used the rat models of middle cerebral artery occlusion (MCAO) and reperfusion to investigate the effects of treatments with doxycycline against the blood-brain barrier (BBB) leakage at 3, 12, 72, and 120 h of reperfusion. |
T4 | 779-937 | DRI_Background | denotes | Male Sprague-Dawley rats were subjected to MCAO for 2 h followed by reperfusion for 3, 12, 72, and 120 h and received either doxycycline (45 mg/kg) or saline. |
T5 | 938-1113 | DRI_Outcome | denotes | The results showed that the treatment of doxycycline significantly reduced the BBB leakage and cerebral infarct volume, which were proved by Evans blue assay and TTC staining. |
T6 | 1114-1346 | DRI_Background | denotes | Real-time PCR, immunohistochemistry, and western blot assay verified that the administration of doxycycline significantly up-regulated the expression of tight junction claudin-5, occludin, and ZO-1 from 3 to 120 h after reperfusion. |
T7 | 1347-1681 | DRI_Outcome | denotes | The results of real-time PCR, western blot, and gelatin zymography analyses revealed that the gene and protein expression and activities of matrix metalloproteinases (MMPs) MMP-2 and MMP-9 were significantly elevated in a different time-dependent manner after ischemia-reperfusion but significantly inhibited by doxycycline treatment. |
T8 | 1682-1810 | DRI_Outcome | denotes | Moreover, doxycycline could also significantly down-regulate the expression of PKCδ mRNA and protein after ischemia-reperfusion. |
T9 | 1811-2026 | DRI_Background | denotes | These results suggested that the protective effects of doxycycline against BBB damage induced by reperfusion might be related to the up-regulation of tight junction proteins and inhibition of MMP-2, MMP-9, and PKCδ. |
Allie
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
SS1_22173873_3_0 | 579-611 | expanded | denotes | middle cerebral artery occlusion |
SS2_22173873_3_0 | 613-617 | abbr | denotes | MCAO |
SS1_22173873_3_1 | 705-724 | expanded | denotes | blood-brain barrier |
SS2_22173873_3_1 | 726-729 | abbr | denotes | BBB |
SS1_22173873_7_0 | 1487-1512 | expanded | denotes | matrix metalloproteinases |
SS2_22173873_7_0 | 1514-1518 | abbr | denotes | MMPs |
AE1_22173873_3_0 | SS1_22173873_3_0 | SS2_22173873_3_0 | abbreviatedTo | middle cerebral artery occlusion,MCAO |
AE1_22173873_3_1 | SS1_22173873_3_1 | SS2_22173873_3_1 | abbreviatedTo | blood-brain barrier,BBB |
AE1_22173873_7_0 | SS1_22173873_7_0 | SS2_22173873_7_0 | abbreviatedTo | matrix metalloproteinases,MMPs |
PubmedHPO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 268-285 | HP_0002637 | denotes | cerebral ischemia |
T2 | 343-349 | HP_0001297 | denotes | stroke |